Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
source : Www.globenewswire.com    save search
Raymond James Financial Reports Fiscal Second Quarter of 2024 Results
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
RJF 4 | $127.54 0.32% 0.0% 1.3M twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
financial results
Wearable Devices Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
WLDS | $0.4548 -4.25% 2.86% 150K twitter stocktwits trandingview |
| Email alert Add to watchlist
nasdaq granted extension
Madrigal Statement on the Passing of Dr. Stephen Harrison
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
MDGL | $204.51 -6.35% -6.78% 580K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
FRLN | $6.48 0.0% 0 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
disease cell meeting parkinson’s therapy
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
KRON | $0.9644 1.52% 1.49% 880K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
kb-0742 update meeting trial
Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
ACRV | $9.46 -3.67% -3.81% 300K twitter stocktwits trandingview |
| Email alert Add to watchlist
acr-368 positive pipeline for program therapeutics today
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Oncology Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
FGEN | $0.9844 -8.0% -8.7% 2.2M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
fg-3246 cancer meeting study
ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
CLPT | $5.33 -3.09% -3.19% 59K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
system for market
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
CRBP | $35.5 -5.94% -6.37% 220K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation asco pharmaceuticals for meeting
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
POAI | $1.34 3.88% 3.73% 24K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation for meeting
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
SNSE | $0.96 -3.78% -3.93% 55K twitter stocktwits trandingview |
| Email alert Add to watchlist
sns-101 asco topline meeting study
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
TCRX | News 3 d | $7.39 1.79% 1.76% 91K twitter stocktwits trandingview |
Professional, Scientific, and T...
 | Email alert Add to watchlist
meeting therapeutics
Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
CDTX | News | $11.94 16.49% 14.15% 170K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
cloudbreak rezafungin pipeline therapeutics development
Great Lakes Announces New $150,000,000 Second-Lien Financing Agreement
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
GLDD 4 | $7.45 -2.36% -2.42% 230K twitter stocktwits trandingview |
Industrial Services
 | Email alert Add to watchlist
agreement
Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
ITCI 4 d | $73.02 -1.34% -1.36% 730K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
MS | News 0 d | $93.85 0.1% 0.0% 4.8M twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
million offering
Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
VERO | $0.76 0.0% 8.1K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
first
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 15, 2024
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
NDAQ | $61.51 0.69% 0.68% 2.8M twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
nasdaq
Splash Beverage Group Names Julius Ivancsits as Chief Financial Officer
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
SBEV | $0.329 2.49% 0.0% 78K twitter stocktwits trandingview |
Health Care and Social Assistan...
 | Email alert Add to watchlist
group financial
Dave & Buster’s Appoints New Chief Financial Officer
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
PLAY F | $53.32 -5.01% -5.27% 1.9M twitter stocktwits trandingview |
Consumer Services
 | Email alert Add to watchlist
financial
Cytokinetics to Announce First Quarter Results on May 8, 2024
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
CYTK | $66.76 1.82% 1.78% 810K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
first results
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services
BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services
WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services
AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services
MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information
RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance
Your saved searches
Save your searches and get alerts when important news are released.